Dr. Zampaglione is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
33 Kanouse Ln
Montville, NJ 07045Phone+1 973-396-2476
Education & Training
Albert Einstein Healthcare NetworkResidency, Obstetrics and Gynecology, 1995 - 1999
Lewis Katz School of Medicine at Temple UniversityClass of 1995
Certifications & Licensure
NJ State Medical License 1999 - 2025
Awards, Honors, & Recognition
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Publications & Presentations
PubMed
- Iron deficiency anemia in patients with heavy menstrual bleeding: The patients' perspective from diagnosis to treatment.Imo J Akpan, Mohit Narang, Edio Zampaglione, Steve Marshall, Dawn Stefanik
Women's Health. 2025-02-27 - 6 citationsRetrospective analysis of variation in heavy menstrual bleeding treatments by age and underlying cause.R. Copher, Le Nestour E, Amy Law, Jennifer Pocoski, E. Zampaglione
Current Medical Research and Opinion. 2013-01-11 - 136 citationsSafety and efficacy of Implanon, a single-rod implantable contraceptive containing etonogestrel.Sidney Funk, Michael M. Miller, Daniel R. Mishell, David F. Archer, Alfred N. Poindexter
Contraception. 2005-05-01
Press Mentions
Mirena sNDA Seeks to Extend Contraceptive Use for up to 6 YearsOctober 22nd, 2019
Bayer Submits Supplemental New Drug Application to FDA for Intrauterine Device (IUD) Mirena® (Levonorgestrel-Releasing Intrauterine System) 52 MgOctober 21st, 2019
Long-Term Essure Safety Risks to Be Evaluated by FDA Long After Market WithdrawalDecember 26th, 2018- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
